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In order to complete my Integrated Masters Degree in Veterinary Medicine, I chose to 
participate in a three-week externship at the VeterinariMolins Veterinary Hospital in Barcelona. 
Following this training, I also took part in a thirteen-week externship in Tennessee, at the 
University of Tennessee College of Veterinary Medicine (“UTCVM”). These sixteen weeks of 
training were mainly focused on small animal medicine and surgery, and provided an 
opportunity to be closely guided and supervised by certified clinicians and specialists. 
At the VeterinariMolins Veterinary Hospital I worked closely with certified veterinary 
physicians in performing consultations, identifying clinical signs, undertaking general and 
complementary examinations, as well as performing diagnostic exams in order to determine the 
patients’ condition and illness, and propose a treatment plan. In cases where the surgical 
approach was warranted, I participated or observed in the procedure. 
At the UTCVM, I participated in the Oncology, Ophthalmology, Community Practice, 
Nutrition, Anesthesiology, Dermatology and Neurology rotations. During this time, I acted as 
primary physician by taking full responsibility for my patients, performing patient rechecks, 
suggesting and completing chemotherapy protocols, participating in daily rounds, taking part in 
surgery and pre and post-surgical care, and suggesting and executing a anesthetic protocols. I 
also received training in spay and neuter procedures, where I was able to act as main surgeon, 
and also in discussions concerning scientific articles. 
These experiences allowed me to put in practice the knowledge I acquired during my 
five-year studies, and I found myself to be fully fulfilled by the path I have chosen. Additionally, 
these externships allowed me to gain a better grasp of the Spanish and English languages, thus 







I would like to express my gratitude to my family for providing me the opportunity to 
pursue my dream of becoming a Veterinary Medicine Doctor. I would like to specially thank my 
Parents, M. Angela Coelho and Francisco Coelho for being such an example of hard work and 
success. For having always believed in me giving me the strength and the advice I needed 
when I thought I was not able to accomplish my dream.  
I am grateful to all my brothers and Sisters, Sofia, João, Nuno and Teresinha for all the 
complicity of being my big brothers and helping grow. The Coelho 5! 
I am grateful to my dear niece Laura Tereno, for being “my person” supporting, earing 
and helping me no matter what or where.  
I am grateful to my Dalila, for all this 14-years, for inspiring and showing me what was 
my path in this world. Because of you in at such young age I learned to love nature and respect 
all the beings equally. Looks like you want to live me now that your mission is done,, but I hope 
that you will stay with me longer because I still need you. There will never be another cat like 
you. 
I am grateful to all my friends in all the cities in world where I have lived in, for enriching 
the experience of studding to be a veterinary doctor. Thank you Ana Maria Andrade, Mariana 
Machado, Sofia Norbrega, Joana Guimarães e Joana Bastos, Joana Cardoso, Ivone Silva, 
Marta Sousa and Cristinana justo. 
I am grateful to S.O.T.A.O, for all the friends and great moments. Like Abel Salazar Said 
“O Médico Que Só Sabe Medicina, Nem Medicina Sabe”. 
I would also like to thank my Supervisor, Dr. Augusto de Matos, for all for all his help and 
for his teachings concerning medicine, responsibility and politeness. Thank you for always 
being so inspiring and challenging. 
I would also like to acknowledge Dr. Legendre, Dr Smrkovsky, Dr Cain, Dr Narak and Dr 
Holford for teaching me and making me feel that I could go further in my future profession. I am 
grateful to all the members of the UTCVM for all their kindness, friendship and teachings. 
Likewise, I am grateful to the VeterinariMolins Hospital and all its veterinary team, 
especially to Dr. Jordi, Grau and Dr Xavier Ribó for transmitting so much knowledge. Thank you 
Dr Xavier for always sharing knowledge and quizzing me about the cases you knew I was 
interested in.  
To ICBAS, for accepting me in and to all to all the teachers that helped me build the 








½: Half ½: Half 
% : percent % : percent 
<: less than  <: less than  
AR: aldose reductase  AR: aldose reductase  
ARI: aldose reductase inhibitor  ARI: aldose reductase inhibitor  
ASA: American Society of 
anesthesiologists  
ASA: American Society of 
anesthesiologists  
BID: twice a day BID: twice a day 
CNS: central nervous system CNS: central nervous system 
bpm: Beats per minute  bpm: Beats per minute  
DM: Diabetes Mellitus  DM: Diabetes Mellitus  
DTM: Dermatophyte Test Medium DTM: Dermatophyte Test Medium 
ECG: electrocardiogram ECG: electrocardiogram 
ERG: Electroretinography  ERG: Electroretinography  
ETCO2: End-tidal pressure of carbon 
dioxide  
ETCO2: End-tidal pressure of carbon 
dioxide  
F: Fahrenheit  F: Fahrenheit  
FeLV: feline leukemia virus infection FeLV: feline leukemia virus infection 
FIV: feline immunodeficiency virus infection FIV: feline immunodeficiency virus 
infection 
HD: hypersensitivity dermatitis HD: hypersensitivity dermatitis 
ICLE: intracapsular lens extraction  ICLE: intracapsular lens extraction  
Kg: kilogram  Kg: kilogram  
Lbs: Pounds Lbs: Pounds 
IgE: Immunoglobulin E IgE: Immunoglobulin E 
LIU: lens-induced uveitis LIU: lens-induced uveitis 
min: Minute  min: Minute  
mmHg: millimeter of mercury mmHg: millimeter of mercury 
mm: Millimeter mm: Millimeter 
mg: milligrams mg: milligrams 










Abbreviation Index …………………………….…………………………...…………………..v 
General Index ……….……………………………………………………...…………………..vi 
Case report nº 1: Ophthalmology ……………….......…………………...…………………..1 
Case report nº 2: Neurology ……………..…………………………...……………………….7 
Case report nº 3: Dermatology ………………………………...…..………………………..13 
Case report nº 4: Oncology ………….............................…….......……………………….19 
Case report nº 5: Anesthesiology....……...........………………….………………………. 25 




Ophthalmology Case Report 
Signalment and motive for consultation: Spice is a 12-year-old female spayed canine 
Miniature Pinscher that was presented to the UTCVM Ophthalmology service for 
phacoemulsification surgery. 
Anamnesis: Spice was diagnosed with diabetes mellitus (DM) by the referring veterinarian. Her 
DM is stable and currently well controlled. She receives 3 units of NHP Insulin SQ, bid, 30 min 
after every meal. The last fructosamine measurement made by the referring veterinarian (15 
days before surgery) revealed a result of 324 umol/L (excellent range: 300-350 umol/L).  
Spice´s first vision problems (bumping into objects and decreased level of activity) were noticed 
by the owners 2 month after with the diagnosis of DM. At the time she had mature cataract OD 
and immature cataract OS. She was seen with a mild lens-induced anterior uveitis that was 
managed with neomycin, polymyxin B and dexamethasone eye-drops, 1 drop OU, sid for 1 
month. In order to evaluate if she was a good candidate for phacoemulsification, the referring 
veterinarian performed an ocular ultrasound (US) and electroretinography (ERG). (Appendix I) 
On US, bilateral primary intumescent cataracts were identified, anterior chambers were shallow  
and no retinal detachment was noticed. Spice´s ERG showed a normal retinal function OU. 
Spice was considered a good candidate for surgery and was referred to UTCVM. To date, she 
was being medicated with 0.03% flurbiprofen 1 drop OU sid. Her vaccines were up to date and 
she was dewormed. Spice lived in a house with a private garden, had no contact with other 
animals nor with toxic waste or garbage. Spice was fed with dry Hills W/D® prescription diet®. 
No other historic abnormalities were identified. 
 Physical Exam: Spice was alert with a normal behavior. She was overweight (4.8 Kg) and had 
a BCS of 8/9. She had a normal respiratory rate (44 rpm) and pattern and also normal heart and 
lung sounds. Her pulse was bilateral, symmetric, strong, and synchronous with a frequency of 
108 p.p.m. Her mucous membranes were pink and moist with CRT<2 sec. Spice´s rectal 
temperature was 38ºC, and no parasites or blood were seen on the thermometer after retrieving 
it from the anus. Normal anal tonus was observed. A dehydration degree of <5% was noticed. 
All lymph nodes were within the normal limits. No abnormalities were found in her abdominal 
palpation. Ears showed no abnormalities. Lens opacification was noticed OU. Moderate dental 
tartar, mild stomatitis and several missing teeth were detected.  
Ophthalmological exam: Spice had direct and consensual pupillary reflexes (PLR´s). No 
orbital asymmetry was observed, the globes were normal in size and position with no 
strabismus. Lids and nictitating membrane were normally positioned and had a normal 
conformation. She presented normal palpebral reflexes and normal masticatory muscles. There 
was no ocular dischargeand bulbar conjunctiva was normal OU. To access Spice´s vision a 
menace reflex and cotton ball test were performed. She was blind OU, had absent menace 
reflexes and didn´t pay any attention to the cotton ball´s path. Slit-lamp biomicroscopy was used 
to exam the cornea, anterior chamber, pupil and iris. The corneas were clear, transparent, 
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convex and fluorescein negatives. The anterior chambers had no flair or other abnormalities, iris 
and pupil were also normal. Lenses had a normal position but were completely opaque. The 
Schirmer tear test was normal OU (22 mm/min OD and 20 mm/min OS; reference range 
<15mm/min). Intra-ocular pressures (IOP) were evaluated with applanation tonometry and the 
results were 4 mmHg OD and 6 mmHg OS, (reference range: 15-25 mmHg). These low values 
can be explained by the diagnosed lens induced uveitis. Indirect monocular ophthalmoscopy 
was used to attempt a fundic examination but, due to lens opacity, this was not possible.  
Diagnostics: CBC: without abnormalities; Serum biochemical analysis: Hyperglycemia 
(Glucose: 124 mg/dL; Normal range: 84-120 mg/dL) hypercholesterolemia (Cholesterol: 504 
mg/dL; normal range: 148-337 mg/dL). Urinalysis: without abnormalities 
Problem List: Blindness, lens opacification OU, hyperglycemia, glycosuria, obesity and 
hypercholesterolemia.  
Differential diagnosis: Lens opacity: Cataracts, nuclear sclerosis.  
Blindness: Cataracts, retinal detachment, progressive retinal atrophy (PRA).  
Diagnosis: Mature diabetic cataracts OU.  
Treatment: 24h pre-operatory: 1%prednisone acetate, 0.03% flurbiprofen, 2.5% phenylephrine, 
1% tropicamide and triple antibiotic solution (Neomicin, Polimixin, Gramicidin), 1 drop of each 
OU  every 3 hours. Tepoxalin 50 mg, PO sid. Spice´s blood glucose was 75 mg/dL 30 min after 
feeding and no insulin was administered. 2h pre-operatory: The same topic drugs were 
administered: 1 drop of each OU every 30 min. Tepoxalin 50 mg PO Sid. Cefazolin 22 mg/kg IV 
was given 30 min before surgery and every 90 min until the end of it. Glycaemia of 354 mg/dL, 
1unit of NPH was given. Phacoemulsification Surgery: In the left eye a foldable 13 mm 60-v 
prosthetic lens was injected into the empty lens capsule after the phacoemulsifier was used to 
ultrasonically liquefy and aspirate the lens using a “divide and conquer” technique. In the right 
eye the anterior chamber was shallow due to partial lens subluxation into the anterior chamber. 
Complete zonular disinsertion was noted from 3 to 9 o´clock. The capsulotomy was performed 
and hydrodissection was not done. Initially phacoemulsification was routine but after creating 
grooves and prior to nuclear removal, vitreous was noted within the lens capsule at 4-o´clock 
position. It was determined that intracapsular lens extraction (ICLE) would be necessary and the 
eye was left aphakic. Tissue plasminogen activator was injected intracamerally OU.  
Post operatory: Spice spent the night in ICU. Triple antibiotic, 1% prednisolone acetate and a 
lubrication solution were administered every 4 hours. IOP´s were controlled 3 times, every 3 
hours and were always normal (OD: 10 mmHg OS: 3 mmHg). First day post-operatory: 1 drop 
OU of: 1% prednisone acetate, 0.03% flurbiprofen, 1% tropicamide, triple antibiotic and 
dorzolamide hydrochloride and timolol maleate solution (cosopt®- Merck). Normal menace 
reflex was noticed OU. The PLR´s were not evaluated due to iatrogenic midriasis. In the anterior 
chamber +1 flare was present OU. Corneal edema was noticed in the right eye. IOP´s were 9 
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OS and 21 OD. No fundic abnormalities were noticed OU. Spice morning blood glucose was 
504 mg/dL but because she did not eat her meal, only 2 units of NPH were given. Spice was 
discharged with prescription of: 1% prednisone acetate: 1 drop OU qid; 0.03% flurbiprofen: 1 
drop OU qid; 1% tropicamide: 1 drop OU bid; triple antibiotic: 1 drop OU qid; lubricating gel: 1 
strip OU qid and prednisone: 5mg PO sid for five days. After these five days, this dose should 
be decreased for ½ tablet sid for another 5 days. After this, ½ tablet should be given every other 
day for 5 days. Spice insulin administration routine (3 units 30 min after every meal) was 
restored.  
1º week recheck: Normal menace reflex OU; Normal direct and consensual PLR OU. IOP´s: 13 
mmHg OD and 15 mmHg OS. Schirmer test: 15 mm/min OD and 17 mm/min OS. Corneas: 
Clear and fluorescein negatives; Anterior Chamber: +1 flare OU; Iris and pupil: normal; fundic 
examination: no abnormalities OU. On Spice´s first week post-surgica recheck, she seemed to 
be enjoying good vision. The owner said that she was more active and was not bumping into 
objects anymore. A mild flare OU was noticed. Spice continued the same medication as 
previously described.  
Assessment: The lens is an avascular, transparent and structured tissue with ectodermal origin 
that, in the normal eye, refracts incoming light rays on the retina. Lens disorders may be 
classified into abnormal embryologic development, abnormalities in transparency and lens 
position within the eye. The loss of transparency is a common denominator of all lens diseases. 
The transparency within the lens is maintained by complex factors: Low cytoplasm density, lack 
of intracellular organelles, absence of nuclei in the lens fibers, small spatial fluctuations of the 
refractive index of cytoplasm, and highly organized lattice arrangement of fiber cells. Those are 
influenced by cytoplasmic hydration, ionic strength and specialized metabolic functions in the 
lens (Gelatt 2007). The lens is rich in protein (35%) and water (65%) and poor in minerals. The 
proteins are divided into soluble proteins (crystallins) and insoluble (albuminoid) proteins (Ofri 
2008). Cataracts formation is associated with pathologic alterations that increase albuminoids 
and decreases crystallins. As the cataract matures the hydrolytic and proteolytic enzyme activity 
increases (Gelatt 2007). The lens proteins break into polypeptides and amino acids that diffuse 
through the lens capsule into the anterior and posterior chambers. Also, the rapidly forming 
cataracts and the lens swelling (diabetes mellitus) cause small tears in the lens capsule. These 
molecules are not recognized by the eye’s immune system because the embryology of the lens 
is such that the lens capsule isolates the lens from the immune system before birth. Therefore 
when the lens proteins enter in the aqueous, they elicit an inflammatory reaction known as lens-
induced uveitis (LIU) that may be acute or chronic (Ofri 2008). This was described and treated 
by Spice´s referring veterinarian and explain the observed low IOP´s OU.  
Throughout life, new lens cells are formed in the equator, forcing older cells toward the nucleus. 
The nucleus becomes denser and, when this becomes visible, it is called nuclear sclerosis. In 
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advanced cases nuclear sclerosis is similar to cataract and for this reason, it was our first 
differential diagnosis. The opacity found in Spice’s lens did not allow the visualization of the 
fundus. This observation permits differentiating between the two entities. The retroillumination 
from the tapetum highlights the cataract opacities, distinguishing them from the transparent 
nuclear sclerosis. In most animals, nuclear sclerosis has a minimal effect in vision, the fundus 
can be visualized and menace is present (Ofri 2008).  
Because the lens is avascular, its metabolic needs are met by the aqueous humor. Alterations 
in aqueous composition affect lens metabolism and transparency. Metabolism of glucose 
provides most of the energy requirements of the lens. Glucose enters from the aqueous by both 
diffusion and assisted transport. Most of the glucose is broken down anaerobically to lactic acid 
via the hexokinase (pentose phosphate) pathway, although some aerobic glycolysis occurs via 
the citric acid cycle. Elevation in glucose levels (in diabetic patients) inhibits the hexokinase 
enzyme. The glucose is diverted into the sorbitol shunt, where it is converted by aldose 
reductase (AR) into sorbitol (Gelatt 2007). The resulting hyperosmolality of the lens leads to 
fluid ingress. Initial changes include vacuole formation along the equatorial cortex that 
progresses to the anterior and posterior cortex. As more fluid enters the lens and the cataract 
matures, it may swell dramatically, this is a phenomenon known as an intumescent cataract. 
The swollen lens may push the iris forward, resulting in a shallow anterior chamber as seen in 
Spice´s eyes. This can also predispose to glaucoma because the iridocorneal angle is 
narrowed. The most prevalent ocular sign of diabetes mellitus in the dog is bilateral cataracts 
that may mature in a very short time course (days to weeks) (Ofri 2008). The diabetic cataract 
formation is dependent on the levels of AR. The use of aldose reductase inhibitors (ARI´s) 
showed to be effective in delaying the onset and/or progression of cataracts in dogs with DM 
(Kador et al. 2010). However this is not significant in lens with advanced changes like the ones 
noticed in Spice, and was not considered a viable treatment in her case. It may have a 
significant impact if used in dogs newly diagnosed with DM, if used continuously and 
indefinitely. For this to be successful good owner compliance is needed. (Kador et al. 2010) 
The stage of development is the most used form of classification in canine cataract. It 
determines the extent of visual deficits, the onset of lens-induced uveitis, and the time of 
surgical intervention: Incipient: early, focal opacity with unaffected sight; Immature: more 
extensive opacity (most of the lens is involved). The transparency of the lens is reduced but not 
totally lost (tapetal reflection is still visible, but fundus may be partially obscured). Vision is 
affected but the animal is still visual; Mature: The lens is totally opaque and we have blindness. 
No tapetal reflection is noticed and the fundus cannot be examined; Hypermature: when mature 
cataracts progress into hypermaturity, they begin to liquefy (lens resorption). (Ofri, 2008) Based 
on this knowledge, on the fact that Spice had diabetes mellitus, and on her clinical signs 
(blindness, lenses generalized opacity), Spice was diagnosed with mature diabetic cataracts. 
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Surgical removal is the only method by which cataracts can be effectively treated, although 
surgical success is not guaranteed (success rates: 85% to 90%). Many dogs do not undergo 
surgery due to owner´s financial constraints, concurrent ophthalmic disease (e.g. retinal 
degeneration), or systemic disease that may preclude general anesthesia. Some owners prefer 
medical treatment or no treatment at all, when confronted with the potential complications of 
phacoemulsification (Lim et al., 2011): Postoperative ocular hypertension (22.9%) corneal lipid 
opacity (19.0%), uveitis (16.2%) intraocular hemorrhage (12.3%), retinal detachment (8.4%) and 
glaucoma (6.7%) (Klein et al., 2011). However, globe threatening complications are much 
higher in dogs receiving topical medical treatment or receiving no treatment at all when 
compared with dogs undergoing surgery (Lim et al., 2011). Spice was diagnosed with cataracts 
before they had become mature. Failure rates for dogs receiving or not receiving treatment 
were higher in dogs with mature or hypermature cataracts when compared with immature 
cataracts. For this reason it would have been beneficial to have referred Spice sooner, before 
the cataracts became mature (Lim et al., 2011).  
The zonular instability observed during surgery may be present in hypermature cataracts, in 
older dogs, or be secondary to uveitis and intumescence of cataracts such as in diabetic 
cataracts (Ofri, 2007). No clinical signs of luxation were noticed before surgery. In the ocular US 
the anterior chamber was shallow bilaterally, but the lenses were still in their normal position. 
The treatment for dislocated lenses is the surgical removal through ICLE. The presence of lens 
in the anterior chamber can lead to complications such as pupillary block, glaucoma or corneal 
edema (Gelatt, 2007). 
In order to maximize a successful surgical outcome, determining if the patient is a good 
candidate to phacoemulsification is essential. At first, the animal should be evaluated for 
systemic disease; secondly a good vision history and ophthalmic examination are required. 
Special attention should be paid to vision loss prior to the onset of cataract, or a history of 
nyctalopia (PRA suspicion). Patient temperament should be accessed because the exercise 
restriction after surgery and the administration of medications are essential for a successful 
outcome. Additional diagnostics include a B-scan US that is used to evaluate vitreal 
degeneration, retinal detachment, axial length of the lens and globe and the presence of 
spontaneous lens capsule rupture. An ERG is also indicated to determine retinal function and 
evaluate for the possibility of PRA. (Gelatt, 2007) The ERG in patients with Diabetes mellitus 
seems to have an amplitude reduction and timing delays of all components. Patients may have 
a reduced ERG preoperatively but a normal fundic examination and vision testing 
postoperatively. This suggests that ERG may be capable of detecting early diabetic retinopathy. 
(Safatle et al., 2010)  
The goal of the preoperative therapy is to achieve mydriasis for surgical exposure, suppress 
ocular inflammation and minimize ocular microbial flora. The intraoperative complications of 
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ICLE and extracapsular lens extraction (ECLE) include fibrin accumulation, hemorrhage and 
vitreous expansion. In order to avoid fibrin, an intracameral injection of 25 mcg of tissue 
plasminogen activator (tPA) was used OU. Retinal detachment following ICLE is the second 
most common postoperative complication after secondary glaucoma. This is thought to be a 
result of preexisting retinal tears that enlarge following surgery, and disruption of the anterior 
hyaloid face may predispose eyes to this complication. The fact that the ICLE had been 
performed soon after the luxationmay decrease the chances for this complication (Gelatt, 2007). 
Spice is a successful case; she is able to see and did not develop any complication to date. The 
fact that she was aphakic OD means that she is severely hyperopic because of the loss of the 
refractive power of the lens. However the cornea is the major refractive organ of the eye so 
puzzlement vision is still possible even without an IOL.  
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Signalment and motive for consultation: Quanto is a 6-year-old male castrated German 
Shepherd presented to the UTCVM’s Neurology/Neurosurgery service due to a suspicion of 
lumbosacral stenosis. 
Anamnesis: Quanto had a 9-month history of progressive hind limb lameness. At first, Quanto 
had occasional lameness that seemed to increase with exercise and resolve to some degree 
with rest. Three months before presentation the frequency of lameness increased until he was 
having problems daily. He was unable to jump, difficulting his job as a police dog. Quanto has 
had signs of fecal and urinary suspected incontinence for three weeks, the owner reported that 
Quanto urinated and defecated without posturing to do so. His left hind leg seemed weaker than 
the right, and he dragged his nails when walking. The owner has tried to treat Quanto with 
deracoxib (Deramaxx® Novartis) 1mg/kg sid but did not think it helped. Quanto was a police dog 
and lived with other animals. He was up to date on vaccines, dewormed and eating a high 
quality dry diet. He had always been healthy and no abnormalities were found when the owner 
was questioned about other systems.  
Physical Examination: Quanto was alert and anxious. His body condition score (BCS) was 
4/9, and weighed 36.4 kg. He had a normal respiratory rate (28 rpm) and effort and also normal 
lung and heart sounds. Quanto´s pulse was bilateral, symmetric, strong, and synchronous with 
a frequency of 68 ppm. His mucous membranes were pink and moist with a CRT of <2 sec. His 
rectal temperature was 39ºC, and no parasites or blood were seen on the thermometer after 
retrieving it from the anus; a normal anal tonus was also observed. A dehydration degree of 
<5% was observed in the patient. All lymph nodes were within the normal characteristics. No 
abnormalities were found in his abdominal palpation.  
Neurological exam: Quanto had bilateral pelvic limb lameness and was knuckling his left hind 
foot when walking. He displayed a bunny-hopping gait when running up stairs. He had normal 
cranial nerves. He presented a delayed proprioceptive positioning response. The other  postural 
reactions were accessed and no abnormalities were found. He had a decreased flexor 
withdrawal reflex in his left pelvic limb but all other reflexes were normal. He was painful in his 
lumbosacral area and had mildly decreased muscle tone in his left hind limb. Pain was 
accessed by direct pressure over his lumbosacral joint, rectal palpation and elevation of his tail. 
Quantos lesion was localized to the L4-S2 spinal segments or his cauda equina nerve roots. 
Problem List: Bunny hopping up stairs, decreased left flexor withdrawal reflex, delayed 
proprioceptive positioning response, suspected incontinence, lameness, knuckling left foot while 
walking. 
Differential Diagnosis: Degenerative lumbosacral stenosis (DLSS), diskospondylitis, 
neoplasia, and external injury, arthritis, hip dysplasia and cranial cruciate ruptures. 
Diagnostics: Radiographs: normal hip joints; normal L7-S1 intervertebral space and possible 
osteochondrosis of the cranial endplate of S1. MRI: severe dorsal and ventral stenosis of the 
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lumbosacral junction; stenosis of the intervertebral foramen at the level of the left L7 nerve root. 
CBC: within the normal limits Chemistry panel: No abnormalities were noticed. 
Diagnosis: Degenerative lumbosacral stenosis and left foraminal stenosis. 
Treatment: Surgery: Dorsal laminectomy with removal of mineralized disc material and 
foraminal decompression. The IVD was swabbed for bacterial culture due to the presence of 
fibrillated cartilage in the L7 and S1 endplates that suggested the possibility of diskospondylitis. 
Swabs were submitted for aerobic and anaerobic culture, and no growth was seen in 4 days. 
The bony protuberance reported on MRI was seen on the craniodorsal aspect of S1 but it was 
not possible to remove it due to its localization beneath the spinal nerves. After surgery, Quanto 
was able to walk without knuckling. He was urinating and defecating normally and appeared to 
be comfortable. Quanto was prescribed six weeks of crate rest, gabapentin 10mg/kg PO tid, 
tramadol 3mg/Kg PO bid and carprofen 2mg/kg PO bid for pain management. 
Assessment: The spinal cord and the vertebral column grow at different rates during 
embryonic development. The spinal cord is derived from ectoderm and is shorter than the 
vertebral column, derived from mesoderm. In the majority of dogs, the conus medullaris is 
located in the caudal half of L6 or cranially in L7. At this point, it originates the cauda equina, 
composed by the L6, L7, S1-S3 and Cd1-Cd5 nerve roots, and located between L6 and Cd5 
(Meij & Bergknut 2010). Ventrally, the cauda equina is protected by the dorsal longitudinal 
ligament, the L7-S1 intervertebral disk (IVD) and vertebral bodies. Laterally it is bound by the L7 
and S1 pedicles and intervertebral foramina. Dorsally it is covered by the interarcuate ligament 
and the laminas of L7 and S1. The articulation between L7 and S1 is made by the IVD and the 
synovial facets. It is stabilized by the ventral and dorsal longitudinal ligaments, the interarcuate 
ligament, the interspinous ligament and finally by the sacral fascia and epaxial muscles (Meij & 
Bergknut 2010).  
DLSS is the most common disorder of the lumbosacral junction seen in middle-aged large-
breed dogs, especially in male working German shepherd dogs (GSD). DLSS is caused by a 
combination of anatomic factors that result in the compression of the cauda equina and its blood 
supply. Abnormal motion of the lumbosacral junction due to repetitive stress, genetic and/or 
congenital abnormalities (symmetric or asymmetric transitional or extra vertebrae) seem to 
predispose to L7-S1 disk degeneration (Meij & Bergknut 2010). Dogs with transitional vertebrae 
segments (TVS) have a higher risk of developing this disease due to malarticulation that can 
cause a dysplastic disk, prone to premature degeneration (Worth el al. 2009). Altered joint facet 
orientation was also proposed to cause an abnormal degree of motion of the intervertebral 
articulations, producing mechanical stress in the IVD. German shepherds have distinct 
geometries of the articular facets and a variable asymmetry between the left and right articular 
facets. This may change the weight distribution and explain the predisposition of GSD to DLSS 
(Worth et al. 2009). Sunwankong et al. (2008) concluded that the angles of the L7-S1 joint were 
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more sagittally oriented in GSD than in other breeds and that this could affect the lumbosacral 
motion. However, they were not able to find a relationship between this abnormality and the 
incidence of disk degeneration.  
The IVD degeneration begins with the degradation of proteoglycans. Subsequently, the water 
and nutritional supplies diminish and the disk loses its width. The unstable spinal segment 
changes the weight bearing from the central axis of the IVD to the peripheral parts of the spine, 
the joints facets and ventral aspect of the vertebral bodies. A ventral subluxation of S1 can 
occur and contributes to more compression (Meij & Bergknut 2010). Although this was 
considered a signal of lumbosacral instability seen in the majority of dogs in one study, the size 
of the step did not correlate to clinical signs (Sunwankong et al. 2008). In order to compensate 
for the increasing instability, a proliferation of the soft tissues occurs (hypertrophy of the 
interarcuate ligament and joint capsules and epidural fibrosis). The cartilaginous end plates 
thicken and osteophytes and ventral spondylosis can form. All of this contributes to the 
abnormal disk nutritional supply. The narrowing of the IVD and the loss of annulus fibrosus (AF) 
tensile strength causes bulging of the AF and Hansen II herniation (Meij & Bergknut 2010).  
The most common clinical signs of DLSS are lumbar pain, difficulty rising (that can be confused 
with hip dysplasia and orthopedic disorders) and recurring lameness of one or both pelvic limbs. 
The inability to jump and difficulty in climbing stairs are also described. Exercise usually 
exacerbates the signs secondary to intermittent claudication and may resolve to some degree 
with rest. The fact that lameness worsens with exercise and resolves to some degree with rest 
can be indicative of neurogenic lameness. This is due to failure of arterial vasodilatation in the 
affected nerve roots during exercise because of compression. Pelvic limp paresis only occurs in 
advanced cases. Because there may be pain with no neurological deficist and it may be difficult 
to distinguish pain associated with spinal disease from the one caused by orthopedic problems. 
Eliciting pain with over the lumbosacral joint supporting the animal´s pelvis, lifting its feet or by 
rectal palpation can help to differentiate lumbosacral pain from orthopedic disease. Pain can 
also be elicited by the elevation of the tail and than rotating the lumbosacral joint by swinging 
the hind limbs. (Sharp & Wheeler 2005) 
Only in later stages the disease progress to paraparesis. The weakness involves the muscles 
innervated by the sciatic nerve, so a decreased extension of the hock and a plantigrade stance 
are noticed. Fecal and urinary incontinence are related to compression of the sacral nerves 
(pelvic and pudendal nerve dysfunction) the urinary incontinence is of the lower motor neuron 
(LMN) type, characterized by dribbling of urine and a bladder that is easily express by manual 
pressure. Fecal incontinence seems to be related with poor anal tone, which can be present 
even with an intact anal reflex. (Sharp & Wheeler 2005) 
 Key to clinical diagnosis is the localization of pain in the lumbosacral region without painful hip 
joints although diseases like neoplasia, diskospondylitis and synovial cyst(s) compressing the 
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lumbosacral area present similar clinical signs. Orthopedic diseases such as arthritis, hip 
dysplasia and cranial cruciate ruptures are also differential diagnoses (Lorenz et al. 2011).  
Clinical signs and anamnesis were important to define Quanto´s hind limb lesion as chronic 
progressive and bilateral. With the neurological examination we were able to localize it.. 
Because Quanto had normal bilateral patellar reflexes, we were able to localize the lesion 
caudally to L6. However the patellar reflex can be exaggerated when the sciatic nerve is 
depressed. This phenomenon is called pseudo-hyperreflexia and is due to decreased tone in 
the muscles innervated by the sciatic nerve wich are responsible for counteract the extension of 
the stifle that is induced by the patellar reflex. This pseudo-hyperreflexia must be differentiated 
from the increased patellar reflex that happends with upper motor neuron deficits, in lesions 
cranial to L4 segment (Sharp & Wheeler 2005). The withdrawal reflex of the pelvic limb 
evaluates primarily the sciatic nerve and its spinal cord segments (L6, L7 and S1). The motor 
response of this reflex is the flexion of all joints, except the hip, controlled by the femoral nerve 
(Lorenz et al. 2011). Quanto had a normal right flexor reflex but decreased flexion on the left 
side. This is a LMN sign that made us suspicious of a possible sciatic lesion. The 
gastrocnemius reflex  and cranial tibial reflexes were normal bilaterally so we concluded that it 
was not a complete sciatic nerve lesion. The perineal reflex was normal. It tests the branches of 
the sacral plexus that are located in the pelvic canal. It is the best indication of the functional 
integrity of the sacral spinal cord segments and nerve roots. Testing this reflex is especially 
important in animals with urinary bladder dysfuncion. Quanto was suspected of having LMN 
incontinence because he did not posturate for urination and defecation but this could also be 
lumbosacral pain related. The fact that he was defecating and urinating normally after surgery 
and the normal perineal reflex made us conclude that quanto has not incontinent. Quanto also 
had a bunny-hopping gait when running up the stairs. No specific location explains this clinical 
sign, but it may be related to lumbosacral pain.  
At this time, our major suspicion was a lesion at L7-S1. Imaging was the first approach to rule 
out bone-associated neoplasia, diskospondylitis, trauma and vertebral abnormalities (Worth et 
al. 2009). Plain radiographs showed no hip joint abnormalities (Appendix II-1). Also, fractures, 
TVS, spondylosis, subluxation of S1, and signs of infectious or neoplastic disease were not 
identified lombo-sacral vertebral column. The L7-S1 intervertebral space did not look narrowed 
on radiographs but osteochondrosis of the cranial endplate of S1 seemed to be present. The 
superimposition of the iliac wings and iliosacral joints made it difficult to detect a small lesion 
such as this on survey radiographs (Appendix II-2).  
In studies, a correlation between neurologic and radiologic findings was not found. Neither the 
width nor the lumbosacral joint angle, nor its malalignment were significantly different between 
dogs with normal and abnormal neurological signs. Also, the step lesion between L7 and the 
sacral canal (S1) has been reported to be present in 69% of dogs with DLSS, but it was also 
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seen in healthy dogs. (Worth et al 2009). 
Myelography is considered by many to be useless in DLSS diagnosis because the dural sac 
terminates cranially to L7 in many dogs. However, the contrast column may cross the 
lumbosacral space in normal and affected dogs. In these dogs, it could be a useful diagnostic 
when CT or MRI are not available. The major limitation of this is the inability to see the 
compression of nerve roots in L7 (Worth et al 2009).  
A CT study is a good diagnostic tool, its advantage being the ability of reformatting dorsal and 
sagital images from transverse planes. However, MRI is the most sensitive for detecting disk 
degeneration, attenuation of normal epidural fat and the compression of nerve roots. Despite 
the advances in imaging diagnostics, CT and MRI results are not as important as clinical signs 
and surgical factors determining prognosis. No correlation was noticed between the severity of 
compression and the severity of clinical signs (Worth et al. 2009).   
A MRI study was considered diagnostic in Quanto´s case. A severe extradural compressive 
lesion caused by T1 and T2 hypointense tissues was noticed in the L7-S1 intervertebral disc 
space. Severe compression of the spinal nerve roots was also identified. Except for the L7-S1, 
all lumbar intervertebral disks were well hydrated (high signal on T2 sequences). This lesion 
was a dehydrated disk protrusion. The cranial endplate of S1 was flattened and irregular at its 
dorsal aspect. There was sclerosis of the cranial endplate of S1, characterized by T1 and T2 
hypointensity. On the proton weight density transverse sequence, there was a separate ovoid 
fragment at the craniodorsal aspect of S1, lying in the left ventral aspect of the vertebral canal 
(Appendix II-3). 
Surgical and conservative treatments are described for the treatment of DLSS. The 
management this disease is based on the evaluation of the severity and duration of the clinical 
signs. Conservative management is indicated only for the first episode of pain or in cases of 
intermittent pain. Confined cage rest for 4 to 8 weeks and pain management with non-steroidal 
anti-inflammatory drugs leads to a recovery rate of 24% to 50%. Signs often recur when 
exercise is resumed (Lorenz et al. 2011). Injections of methylprednisolone sodium acetate into 
the lumbosacral epidural space were described as having shown improvements in 79% of the 
patients (Meij & Bergknut 2010). For this to be successful the dogs cannot have proprioceptive 
deficits or urinary nor fecal incontinence. This is a controversial treatment due to corticosteroid 
side effects like lowering the immune response predisposing to the flare up of unrecognized 
diskospondylitis (Meij & Bergknut 2010). The conservative approach is not curative for the 
underlying cause, but may yield good pain management. This was not an option in Quanto´s 
case because he already had neurologic signs. 
Surgical treatment is indicated when the conservative management fails or when neurologic 
deficits are present. Dorsal laminectomy is the most commonly reported surgical technique. 
This procedure allows for decompression and visualization of the cauda equina. The nerve 
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roots can be retracted laterally for visualization of the disk for diskectomy and relief of 
compression. Dorsal laminectomy has a short-term successful outcome of 41% to 78% (Lorenz 
et al. 2011). Laminectomy alone does not cause instability of the lumbosacral articulation but 
the sum of diskectomy reduces stability (Lorenz et al. 2011). When laminectomy alone may not 
provide enough decompression, techniques like partial discectomy, foraminotomy and 
facetectomy are required for the enlargement of the foramen. The removal of the articular 
processes should be avoided because this is likely to increase limbosacral instability. 
Foraminotomy alone can be performed in cases were the core problem is nerve root 
compression without spinal canal stenosis (Meij & Bergknut 2010). Endoscopic assistance has 
been described to improve intra-operative visualization and avoid the risk of incomplete 
decompression (Worth et al. 2009). Stabilization by fixation and fusion is indicated in dogs with 
S1 subluxation or to prevent further development of lumbosacral instability (Meij & Bergknut 
2010).  
Good postoperative management is essential for a successful outcome. It consists in restricted 
exercise for at least six weeks. Nonsteroidal analgesics may be given to reduce pain during the 
postoperative period (Lorenz 2011). Physiotherapy during rehabilitation can improve long-term 
functional outcome (Meij & Bergknut 2010).  
Prognosis is fair to good when clinical signs improve with surgery and if surgical intervention is 
performed early. Recurrence rates are between 3% and 18% in the working dogs. Severe 
neurological deficits, urinary and fecal incontinence for more than a few weeks before surgery 
are negative prognostic factors. Those animals and have a guarded to poor prognosis. (Lorenz 
et al. 2011).  Quanto was considered to have a excellent prognosis for return to normal 
ambulation and comfort and good prognosis for return to normal working level due to his fast 
recovery after surgery. However being a working dog the possibility of recurrence should be 
considered 
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Signalment and motive for consultation: Pat T Cat is a 13-year-old male castrated American 
domestic shorthair cat, presented to UTCVM’s Dermatology Service for evaluation of a history 
of intensive pruritus. This was his second recheck; furthermore he was presented for allergy 
testing. 
Anamnesis: Pat was described as to being seasonally affected (spring and fall). The patient 
also had a history of responding well to corticosteroid injections (Methylprednisolone). He lives 
with 5 other cats, strictly indoors, with no recent additions of new cats. Pat was vaccinated but 
not treated for internal or external parasites. He supposedly doesn’t have access to toxic waste 
or garbage. No abnormalities were identified concerning other systems. His referring 
veterinarian started Pat and the other household cats on a food trial with Royal Canin 
hypoallergenic® diet and administered Methylprednisolone 5mg/kg SQ on the same date. The 
owners described an initial response to the treatment and food trial, but after approximately 1 
month Pat began showing signs of intense pruritus again. Pat’s physical exam showed him as 
alert and with all vital parameters within normal limits. He weighed 4.9 Kg. His dermatologic 
exam revealed extensive excoriated, crusted and erythematous areas of alopecia over the 
neck, dorsum, abdomen, and periocular, periauricular and axillar areas. He also had miliary 
dermatitis on his dorsum and an indolent ulcer on his upper lip. In addition, his ears were 
erythematous and excoriated, and moderate brown ceruminous debris was observed in the 
external ear canal. A Wood lamp was initially used to attempt to visualize fluorescence of 
dermatophytosis; results were negative. A fungal culture (DTM) was submitted along with full 
blood work (CBC and Chemistry) including a FeLV/FIV test. Superficial and deep skin 
scrapings, along with tape cytologies and impression smears, were also performed in the hope 
of identifying Demodex gatoi or cati, Notoedres cati, Cheyletiella, or bacterial and yeast 
organisms. All the tests were negative. In the skin impression tests, cocci, Malassezia, 
neutrophils and occasional eosinophils were observed. The blood work showed leukocytosis 
(left shift neutrophilia) and eosinophilia. Eosinophilia could be secondary to Pat's allergic 
disease and possible parasitosis. Left shift neutrophilia could be due to the inflamed excoriated 
skin lesions, considering he was not showing evidence of systemic disease. Based mainly on 
the skin cytology evaluation Pat was diagnosed with superficial pyoderma, Malassezia 
dermatitis and bilateral otitis externa (bacterial and yeast).  Since all the other pruritic causes 
were excluded, Pat´s superficial pyoderma and yeast ear infection were thought to be 
secondary to allergy. Because Pat's owners had difficulty administering oral medications, he 
was given cefovecin sodium (Convenia®- Pfizer) 7mg/kg SQ. Convenia injections were 
prescribed to be administered by the referring veterinarian every two weeks until 2 weeks after 
the pyoderma was cured. This particular antibiotic was selected mainly for the owner’s 
convenience (relatively long lasting effect of this drug allows for dosing every two weeks) and its 
broad spectrum. In order to address his current pruritus, Dexamethasone Sodium Phosphate at 
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2mg/kg SQ was administered once at presentation. This corticosteroid was specifically selected 
for its shorter action span (up to 7-10 days), in order to make intradermal and/or serum testing 
possible in the future. Pat was discharged with instructions to begin a flea and otodectic, 
notoedric, and cheyletiella mites trial, using topic selamectin every 2 weeks for a total of 3 
consecutive treatments. He was also prescribed Cyclosporine A (or CsA) at 7 mg/kg PO, SID as 
an immunomodifying agent. To assess the ear problem Otomax®-merck (gentamicin, 
betamethasone and clotrimazole) at 0.5 mL AU BID was prescribed for 10 days. Furthermore, in 
order to treat Malassezia a shampoo with chlorhexidine, acetic acid and ketoconazole was 
prescribed to be used twice a week. The food trial, at this point, was stopped, both to avoid 
interference with diagnostic tests previously described and because the immunosuppressive 
therapy would render the results from a food trial interpretable  
Four weeks after the first visit, Pat had his first recheck. Less intensity of pruritus (6-7/10) and 
some hair regrowth in the lesions were noticed. A new ear cytology also showed improvement. 
No bacteria were found, and Malassezia were now only identified in his left ear. The skin 
surface cytology still revealed a heavy burden of neutrophils and bacteria (intra/extracellular 
cocci). The blood work revealed left shift neutrophilia, eosinophilia and monocytosis. Chemistry 
panel remained normal. A skin culture was performed and the results of this test showed that 
the organisms (Staphylococcus aureus) were sensible to cefovecin. Under this notion the 
patient was continued on Convenia. Skin and serum allergy testing were considered and 
corticoid medication was not repeated. Ciclosporin and selamectin treatments were continued 
with the same frequency. A 1.5% lidocaine spray and a pramoxine and calamine lotion was 
prescribed for the relief of pruritus. Ten days later Pat had his second recheck exam for allergy 
testing. 
Physical Examination: Pat was alert and showing a normal behavior. His body condition Score 
(BCS) was 5/9, and weighted relatively the same (4,6 Kg). Normal respiratory rate (28 rpm) and 
effort (his respiratory movements were costo-abdominal, regular and the relation between 
inspiration and expiration was 1:1.3, with no use of the accessory muscles of respiration), and 
also normal lung and heart sounds. Bilateral, symmetric, strong and synchronic pulses with a a 
frequency of 168 p.p.m were also observed. Pink and moist mucous membranes with a CRT <2 
sec. His rectal temperature was 38ºC, and no parasites or blood were seen on the thermometer, 
a normal anal tonus was also observed. A dehydration degree of <5% was observed in the 
patient. All lymph nodes were within the normal limits. No abnormalities were found in the 
abdominal palpation. Multiple skin lesions were found (described in dermatological 
examination). 
Dermatological Examination: His dermatologic exam revealed improvement since the last 
visit, but Pat still had extensive excoriated, desquamate, erythematous areas of alopecia over 
his temporal, abdominal, axillar and inter-digital areas although some hair regrowth over these 
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lesions was noticed. Lichenification was seen on the neck, miliary dermatitis was identified on 
his dorsum and an indolent ulcer was present on his upper lip. No parasites were seen and 
normal epilation and normal to dry skin. A decreased in the intensity of the patient’s pruritus was 
evident (now 5/10). 
Problem List: Pruritus 5/10, alopecia, erythema, excoriation, desquamation, indolent ulcers 
and miliary dermatitis. 
Differential Diagnosis: Food allergy; Flea and/or Mosquito bite hypersensitivity; 
Dermatophysosis; Ectoparasites (Cheyletiellosis, Otodectes cynotis, demodecosis or feline 
scabies); Cutaneous lymphoma; Psychogenic alopecia; Pemphigus. 
Diagnostics: Allergy skin test: Negative; Serum allergy test: oak mix +++, quack +, perennial 
rye +, Timothy +, red top +, the rest of tested allergens were negative.  
Diagnosis: Atopy and secondary superficial pyoderma. 
Treatment: Chlorpheniramine 2-4mg sid or bid as needed, Selamectin topically every 3 weeks, 
1.5% lidocaine spray topically in the itchy areas tid, cyclosporine 100mg/mL 25 mg SID, 
pramoxine and calamine lotion in the lesions as needed. 
Assessment: Based on Pat´s history of seasonal and steroid responsive pruritus, either a flea 
and/or environmental allergy were suspected. Although other pruritic causes such as flea and 
mite infestations (Demodex gatoi or cati, Notoedres cati, Cheyletiella) or dermatophytosis (M. 
canis, M. gypseum, and T. mentagrophytes) were considered. Dermatophyte infections are 
often self-limiting and cats usually have a poor inflammatory response. This explains the relative 
tolerance for M. canis, and the high rate of asymptomatic or subclinical carriage of this species 
among cats. Pruritus is usually minimal or absent in fungal infections however, it could 
occasionally be marked suggesting ectoparasitism, allergy or secondary bacterial (usually 
staphylococcal) infection (Muller et al. 2001). This was excluded by Pat´s DTM and woods lamp 
negative results. 
To diagnose the presence of feline mites (Demodex cati, D. gatoi, Notoedres cati and 
Cheyletiella) superficial and deep skin scrapings were made, but were negative. Ear cytology 
was performed and no ear mites were identified. Skin scrapings are diagnostic for these 
conditions but mites can be difficult to find in cats that groom excessively, therefore a short 
therapeutic trial is indicated before more complicated testing are undertaken (Muller et al. 
2001). Based on this, selamectin pipettes were used (3 with 2 week interval) with no significant 
improvement. D. gatoi could still be a possibility as selamectin is not an effective treatment. A 
lime sulfur dip trial weekly for 6 weeks would be needed to be ruled out. Since none of the other 
cats were affected and the pruritus was long-standing with seasonal exacerbation and 
glucocorticoid-responsive. A mite infestation was ruled out but the possibility of having a D. 
Gatoi infestation could be considered in the future depending on the patient´s response (Muller 
et al. 2001). 
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Feline atopy is a type I hypersensitivity reaction to environmental antigens (allergens) 
manifested mainly as a pruritic skin and/or respiratory disease in cats. It is caused by an 
exaggerated or inappropriate response of the affected cat to these environmental allergens 
(Muller et al. 2001). IgE is supposed to have a pivotal role in these conditions but this has not 
been sufficiently studied in cats. Allergen-specific IgE has been detected in the serum of allergic 
cats, but also in healthy cats. Non-IgE mediated reactions may also play a role in the 
development of hypersensitivities in cats. Feline atopy can be seasonal or non-seasonal, 
depending on the offending allergens. The most common environmental allergens are non-
seasonal. House dust mite reaction (predominantly Dermatophagoides farinae) is the most 
prevalent. A genetic or heritable predisposition is suspected. The incidence of the disease is 
controversial; some say it is the most common cause of allergy in cats (73% of all allergic cats) 
or that it is second in incidence to fleabite hypersensitivity (Muller et al. 2001). Clinical signs 
develop at 6 months to 3 years old, and no breed or sex predilections were demonstrated. The 
clinical hallmark of atopic dermatitis in cats is glucocorticoid responsive pruritus. The type of 
skin lesions can vary and clinical manifestation is influenced by the duration of disease, intensity 
of pruritus, and the cat´s behavior. Skin lesions often described include erythema, papules and 
crusted papules (miliary dermatitis), excoriations and linear crusts, exudative lesions, and 
eosinophilic plaques and self induced alopecia or hypotrichia. Eosinophilic plaques may occur 
as single lesions (abdominal area and in the medial thighs) but are often found together with 
other lesions. Eosinophilic ulcers (upper lips) and eosinophilic granulomas (face, head and chin) 
are less common signs of atopy. Lesions are usually found in a symmetrical pattern that often 
includes head, pinnae, neck, abdomen, flanks and limbs. The head lesions occur at the 
preauricular or periocular areas. Erythema and hypotrichia around the lower lips and chin can 
be confused with signs of acne. The incidence of concurrent allergy is unclear but the presence 
of fleabite hypersensitivity and/or food hypersensitivity can greatly complicate the diagnostic 
work-up as well as the therapeutic regimen. Lymphadenomegaly may be found as a sign of 
chronic skin inflammation. Sneezing is reported to be present in 50% of the cases. Chronic 
coughing and asthma may occur, although bronchial hyperreactivity has not been proven to be 
higher in cats with atopy when compared to other allergic diseases (August 2006). These 
clinical presentations are not considered pathognomonic for hypersensitivity dermatitis (HD), 
and the diagnosis of those diseases is usually based on the exclusion of other pruritic 
pathologies. Additionally, responses to dietary restriction, flea control or immune-modulating 
therapy (allergen-specific immunotherapy, glucocorticoids or CsA) are necessary to establish 
the etiological diagnosis of food-associated HD, fleabite HD or atopy. The large phenotypic 
variability of feline non-flea HD has complicated the establishment of definitive diagnostic 
criteria for this disease (Favrot et al.2011). Cats with non-seasonal HD should undergo a 6-8 
week restriction diet to determine the importance of food allergens in the development of the 
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condition and to identify which are the ingredients responsible for the allergic reaction. Allergen-
specific intradermal and/ or IgE serological testing can be used to recognize environmental 
allergens (Hobi et al. 2011). The IgE serum test is considered an unreliable test for atopy in 
cats, as it was proven to be influenced by age, flea control, and deworming status. However it is 
beneficial for the selection of allergens for allergen-specific immunotherapy (Belova et al.2012). 
A definitive diagnosis for feline atopy requires a positive intradermal allergy testing (IDST), but 
this requirement is not met in some atopic cats, like Pat, because reactions, including those to 
histamine, are subtler than in dogs. This may be because IDST in cats, with or without prior 
sedation, produces stress responses. Some atopic cats are as reactive as any dog but whether 
this has any prognostic significance is yet to be determined (Muller et al. 2001). Treatment is 
usually required for life. A flea control program should be instituted to prevent fleabites from 
aggravating the pruritus. Pruritus can be controlled with immunosuppressive drugs and 
immunotherapy. Systemic antihistamines can reduce the clinical signs in 40% to 70% of atopic 
cats. They can be used in combination with glucocorticoids and essential fatty acids. A 
beneficial effect should occur within 1 to 2 weeks. Systemic glucocorticoids are effective and 
inexpensive controlling pruritus in most cases. Chronic usage can carry severe side effects (e.g. 
iatrogenic Cushing’s, diabetes mellitus, pancreatitis and renal failure). Although cats appear 
relatively resistant to the acute and chronic side effects of glucocorticoids, probably because of 
their decreased number of glucocorticoid receptors (Muller et al. 2001). Long-term side effects 
of prednisolone may be a reason for seeking alternative medication. Cyclosporine (CsA) was 
found to be a valuable alternative to prednisolone without serious side effects. It was seen to 
have equal or better effect on pruritus and cutaneous inflammation. No significant difference 
was noticed in remission or in the number of cats that improved between the CsA group and the 
prednisolone group. There was also no difference in response to either CsA or prednisolone 
when comparing the subgroups of cats with or without immediate skin test reactivity to one or 
more allergens. This reflects the recognized inconsistency of skin testing in cats (Wisselink & 
Willemse 2009). Allergen specific immunotherapy can be used when the IDST or the serum 
allergen-specific IgE tests were successful in identifying allergens. Allergens with positive 
scores should be included in the allergy treatment serum. Allergen specific immunotherapy is 
reported to be successful in 60 to 78% of cases and the incidence of side effects is low 
(Trimmer et al.2006) However, most studies included small numbers of cats and do not involve 
long-term follow-up. Additional medications on an intermittent or continual basis may be 
required. Cats can improve within a month or in 1 year (Trimmer et al. 2006). Linear eosinophilic 
granulomas and indolent ulcers tend to respond better than self-induced alopecia (Muller et al. 
2001). There is no absolute answer to when to discontinue the vaccines. Pruritus scores, dose 
and frequency of additional medications may monitor improvement (Trimmer et al.2006). Pat´s 
serum allergy test results were not very exuberant but were thought to correlate well with the 
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patient’s seasonal exacerbation, and immunotherapy was pursued. The identified allergens 
were used to produce a vaccine that hopefully will control his pruritus and wean him out of CsA 
and antihistamines. No information in cats was found regarding the influence of the 
administration of CsA over the test results. Also, the fact that the restriction diet was not 
maintained for a minimum period of 6-8 weeks compromised its interpretation. 
The prognosis for feline atopy is guarded for the cure without hyposensitization but good for 
remission of clinical signs with medical treatment, although some cases are extremely difficult to 
manage. Concurrent fleabite hypersensitivity, food hypersensitivity, and secondary bacterial 
pyoderma greatly interfere with achieving a favorable therapeutic response, and care should be 
taken to alleviate these complications (Muller et al. 2001). 
Bibliography: 
I. Foster A, Roosje P (2006) “Dermatology” in August John R Consultations in feline Internal 
medicine 5th Ed, Elsevier Inc, 229-237 
II.Belova S, Wilhelm S, Linek M, Beco L, Fontaine J, Bergvall K, Favrot C, (2012) “Factors 
affecting allergen-specific IgE Serum Levels in cats” The Canadian Journal of Veterinary 
Research 76, 45-51 
III.Favrot C, Steffant J, Seewald W, Hobi S, Linek M, Marignac G, Olivry T, Beco L, Nett C, 
Fontaine J, Roosje P, Bergvall K, Belova S, Koebrich S, Pin D, Kovalik M, Meury S, Wilhelm S, 
(2011) “Establishment of diagnostic criteria for feline nonflea-induced hypersensitivity 
dermatitis” ESVD and ACVD, Veterinary Dermatology 23, 45-e11 
IV.Hobi S, Linekt M, Marignac G, Olivry T, Beco L, Nett C, Fontaine J, Roosje P, Bergvall K, 
Belova S, Koebrich S, Pin D, Kavalik M, Meury S, Wilhelm S, Favrot C (2011) “Clinical 
characteristic and causes of pruritus in cats: a multicentre study of feline hypersensitivity- 
associated dermatoses” ESVD and ACVD, Veterinary Dermatology 22, 406–413 
V.Muller G, Kirk R, Scott D, Miller W, Griffin C (2001) in Muller G, Kirk R, Scott D, Miller W, Griffin 
C “Skin Immune System and Allergic Skin Diseases” Muller & Kirk's small animal 
dermatology, 6th Ed, W.B.Saunders Company, 207-273, 543-665 
VI.Trimmer A, Griffin C, Rosenkrantz W (2006) “Feline immunotherapy” Clinical technics in 
Small Animal Practice 21,157-161 
VII.Wisselink M, Willemse T, (2009)”The efficacy of cyclosporine A in cats with presumed atopic 





Dermatology Case Report 
Signalment and reason for consultation: Marcy is a 4-year-old Female spayed American 
domestic shorthair cat that was presented to UTCVM’s Oncology Service for a 1-month post-
splenectomy recheck and consideration for chemotherapy for her mast cell disease.  
Anamnesis: Marcy was initially presented to UTCVM Oncology service for further evaluation of 
multifocal cutaneous mast cell tumor (MCT), diagnosed by the referring veterinarian via skin 
biopsy. On presentation, Marcy had multifocal red, raised, ulcerated cutaneous masses ranging 
from 1mm-5mm throughout her body, including the face, head, neck, legs, trunk, back, ventrum. 
The owners reported that she was intensely pruritic (10/10) and unable to sleep well. Diagnostic 
work-up by the Oncology service included repeat skin biopsy (that confirmed MCT) and staging. 
CBC was within normal limits and the chemistry panel showed no abnormalities. On chest 
radiographs there was no evidence of pulmonary metastasis. Abdominal radiographs had no 
visible masses in the abdominal organs but multifocal soft tissue nodules were noted throughout 
her skin. Marcy´s abdominal US showed enlarged spleen. Fine needle aspirates of the spleen 
were collected and cytology was consistent with MCT. Marcy underwent splenectomy as well as 
ileocecocolic lymph node biopsy and liver biopsy for more complete disease staging. There 
were no intraoperative complications. The liver and ileocecocolic lymph node had no mast cell 
infiltration but the spleen biopsy confirmed diffuse splenic mast cell tumor. 
One month after surgery Marcy re-presented with multifocal, raised, ulcerated, hyperemic, 
alopecic, pruritic nodules of unchanged size and location. Some nodules may have looked less 
swollen than pre-surgery. The owner mentioned that Marcy’s pruritus decreased (5/10) and that 
her energy levels increased. She also stated that after surgery some nodules began 
disappearing but a week before presentation she started developing new nodules (especially on 
the head) and became progressively itchier. Marcy was dewormed and up to date on vaccines. 
She was a strictly indoor cat, and had no other animal housemates. She ate medium quality 
moist diet, and had ad libitum dry food of the same quality. Marcy had no contact with toxic 
waste or garbage and was currently being medicated with: Famotidine 1mg/kg PO sid and 
Cetirizine 1mg/kg Bid.  
Physical Examination: Marcy was alert and bright showing a normal behavior. Her body 
condition Score (BCS) was 9/9, and she weighted (6,13 Kg). She had normal respiratory rate 
(24 rpm) and effort (her respiratory movements were costo-abdominal, regular and the relation 
between inspiration and expiration was 1:1.3, with no use of the accessory muscles of 
respiration), and also had normal lung and heart sounds. Bilateral, symmetric, strong and 
synchronic pulses with a frequency of 180 p.p.m were palpated. She had pink and moist 
mucous membranes with a CRT <2 sec. Her rectal temperature was 39ºC, and no parasites or 
blood were seen on the thermometer. The anal tone was normal. A dehydration degree of <5% 
was observed in the patient. All lymph nodes were within normal limits. Abdominal palpation did 
not reveal any abnormalities but as Marcy was tense and obese. Multiple skin lesions were 
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found on the skin of the head, body and extremities. They were multifocal, raised, some 
ulcerated, hyperemic, and alopecic. Marcy was pruritic on physical examination. 
Problem List: Pruritus 5/10; Multifocal raised, ulcerated, hyperemic, alopecic skin nodules;  
Differential Diagnosis: Multiple cutaneous mast cell tumor (diffuse cutaneous mastocytosis), 
urticarial pigmentosa, mastocytic dermatitis of allergic etiology, epitheliotropic lymphoma and 
progressive feline histiocytosis. 
Diagnostics: CBC, chemistry panel with electrolyte and urinalysis were within normal ranges. 
Diagnosis: Feline diffuse cutaneous mastocytic mast cell tumor with spleen involvement. 
Treatment: Famotidine 0.8mg/kg PO sid, Cetirizine 0.8mg/kg Bid, Masitinib 50 mg PO sid, 
Predniosolone 0.8mg/kg PO sid. 
Assessment: MCT´s are the second most frequent cutaneous neoplasia in the cat. They are 
classified histologically as mastocytic MCT and histiocytic (atypical) MCT. The first is more 
common and histologically similar to the MCTs in dogs. The histiocytic MCT form is very rare 
and mast cells comprise only 20% of the cells present. For this reason it can be misdiagnosed 
as granulomatous nodular paniculitis or deep dermatitis. Spontaneous regression can occur 
over a period of 4-24months. (Tham & Vail 2007) 
The mean age for MCT occurrence is 8-9 years, there is no confirmed sex predisposition 
however in a Sabatini & Bettini study males had a higher prevalence although sex was not 
correlated with outcome (Sabatini & Bettini 2010). Siamese cats appear to be predisposed to 
the development of MCTs of both histologic types (Tham & Vail 2007). 
The mastocytic MCT can be either compact (well differentiated) or diffuse (pleomorphic). The 
compact form accounts for 50% to 90% of cases and is associated with more benign behavior. 
The diffuse form is uncommon and behaviorally more malignant.  
The majority of feline cutaneous MCT are behaviorally benign with the metastatic potential 
ranging from 0 to 22%. The cases that do develop metastases are the ones with diffuse 
mastocytic form of disease. When present, systemic involvement has a poor prognosis and may 
have a fatal outcome (North & Banks 2009). Cats with solitary cutaneous MCT were reported to 
survive longer that those with 5 or more nodules (Sabatini & Bettini 2010). 
Visceral MCTs (splenic and intestinal) are more common in the cat than in the dog. Widespread 
dissemination and metastasis are also much more common. The intestinal MCT is the third 
most frequent intestinal tumor in cats after lymphoma and adenocarcinoma. It commonly 
involves the small intestine; colonic involvement is reported in less than 15% of cases. Lesions 
can be solitary or multiple. Metastases to the mesenteric lymph nodes and/or liver are frequent. 
Intestinal MCT is associated with widespread dissemination and has poor prognosis, most -
animals die or are euthanized soon after diagnosis (Tham & Vail 2007). 
Splenic MCT is the most common differential diagnosis for splenic disease in older cats (other 
differentials include: lymphoma, myeloproliferative disease, hemangiosarcoma, hyperplastic 
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nodules and adenocarcinoma) (North & Banks 2009). Studies have shown that 90% of 
metastasis occurs in the liver, 73% in the visceral lymph nodes, 40% in the bone marrow, 20% 
in lung and 17% in the intestines. One third of the patients can also present with peritoneal and 
pleural effusions rich in eosinophils and mast cells. Splenic involvement can be diffuse or less 
commonly nodular. It has been reported that approximately 18% of cats with cutaneous MCTs 
developed splenic metastasis. In contrast to dogs, cats with visceral intestinal form of MCT do 
not have concurrent cutaneous MCT, but metastasis and gastrointestinal ulceration are much 
more common (Tham & Vail 2007). 
Marcy was diagnosed via biopsy with diffuse mastocytic pleomorphic cutaneous MCT with 
splenic involvement. Biopsy of the liver and ileocecal lymph nodes was performed and no mast 
cell infiltration was identified. Diffuse spleen involvement with low mitotic index was also noted. 
Anatomic location and form of feline MCT are known predictors of outcome. For example, 
diffuse pleomorphic cutaneous mast cell tumors are associated with poor prognosis. High 
mitotic index was associated with unfavorable outcome in Sabatini & Bettini study (Sabatini & 
bettini 2010). Although Marcy´s mitotic index was low, she had the disseminated cutaneous 
pleomorphic form of MCT. 
A typical feline cutaneous MTC presentation is a solitary, raised, firm, well-circumscribed, 
hairless, dermal nodule measuring 0.5-3cm in diameter. Lesions are often white but a pink 
erythematous form can occasionally be seen. A pruritic, plaque-like lesion that resembles 
eosinophilic plaques or discrete subcutaneous nodules can occasionally be found. In 20% of the 
cases the nodules are multiple. Head and neck lesion involving the pinna, near the base of the 
ear are the most common sites for presentation. Trunk, limbs, and other miscellaneous sites are 
less commonly involved. MCTs rarely occur within the oral cavity. Intermittent pruritus and 
erythema are common. Self-induced trauma or vascular compromise may result in ulceration. 
Affected cats are otherwise healthy (Tham & Vail 2007). 
Cats with disseminated forms of MCT can have systemic signs of disease. Depression, 
anorexia, weight loss and intermittent vomiting are associated with splenic and intestinal 
involvement. The presence of peritoneal effusion and splenomegaly is suggestive of splenic 
MCT. Cats with intestinal MCT can present with fever, diarrhea with or without bloody stools 
and they are usually ill for several months. Signs related to the release of vasoactive 
components of mast cell granules, including gastrointestinal ulceration, uncontrollable 
hemorrhage, altered smooth muscle tone, hypotensive shock and labored breathing can be 
observed with systemic forms and have episodic nature. Increased expiratory effort can also be 
seen secondary to pleural effusion or anemia, which is present in one third of patients with 
disseminated disease (Tham & Vail 2007). 
FNA cytology is usually diagnostic. This includes FNA of cutaneous lesions, splenic aspirates, 
thoracocentesis and abdominocentesis if pleural or peritoneal effusions are present. Intestinal 
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mass aspirates are less frequently diagnostic. Tissue biopsy and histological assessment is 
needed to diagnose the cutaneous histiocytic form of MCT (Tham & Vail 2007). 
After obtaining histopathologic description, clinical staging is important to determine the extent 
of disease, prescribe the most appropriate treatment, and provide prognostic information. A 
complete blood count (CBC), serum biochemistry and urinalysis should be performed as base 
line diagnostics. Cats with visceral disease can be anemic and 50% have bone marrow 
involvement. Cats with splenic disease can have a striking peripheral mastocytosis 
(>32.000cells/uL). Hyperglobulinemia has also been reported but the cause is still unknown. 
Imaging with thoracic and abdominal radiographs can confirm pleural or peritoneal effusions. 
Abdominal ultrasound helps determine the extent of visceral dissemination, but a laparoscopy 
or a laparotomy may be needed to get a definitive diagnosis in cats with intestinal form of 
disease. For cats with intestinal MCT, ultrasound can be used to delineate the mass and stage 
for regional or distant metastasis. Peripheral mastocytosis is not usually associated with 
intestinal MCTs but eosinophilia has been reported (Tham & Vail 2007). 
Feline MCTs are suspected to have similar carcinogenic mechanism as in dogs. A c-kit gene 
mutation on exon 8 in the extracellular ligand-binding domain has been reported in the cat. The 
c-kit gene encodes for KIT receptor tyrosine kinase, which is a transmembrane protein that 
consists of several immunoglobulin-like domains (IgDs): an extracellular domain, a 
transmembrane domain, and a cytoplasmic kinase domain. The latter is split by a kinase 
sequence insert into adenosine triphospfate (ATP) binding domain and a phosphotransferase 
domain. The KIT protein is expressed in a variety of different tissues and mediates pleiotropic 
biological effects through its ligand – stem cell factor (SCF). A gain-of–function mutation in the 
c-kit gene, which is the protooncogene encoding KIT, has been demonstrated to be associated 
with the pathogenesis of acute myeloid leukaemia, gastrointestinal stromal tumour and 
mastocytosis in humans by inducing constitutive ligand-independent kinase activation (Isotani et 
al.2006). In Sabatini & Bettini study, high KIT immunopositivity, as well as high mitotic and 
proliferative indexes were associated with unfavorable outcome (Sabatini & Bettini 2010). 
Surgery is the treatment of choice for the focal mastocytic form of feline cutaneous MCT. Since 
these lesions are behaviorally benign large margins are not needed, which is fortunate since 
these tumors tend to be located on the head. The incidence of local recurrence after surgical 
excision ranges from 0-24%, the systemic spread varies from 0-22%. If recurrence happens it is 
usually within 6 months of surgery.  The histiocytic form has been reported to regress 
spontaneously, and a “wait and see” approach may be taken when it is found in young cats with 
multiple lesions (Tham & Vail 2007). In cases of diffuse cutaneous mastocytic tumors, like seen 
in Marcy´s case, surgical approach is often not feasible, due to the extent of disease, and 
chemotherapy is needed the only reasonable treatment option. However, the efficacy of 
chemotherapy in feline MCT has not been well established (North & Banks 2009) 
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Cats with splenic MCT are reported to greatly benefit from splenectomy. Even in cases with 
bone marrow and peripheral blood involvement, long term survival (12 to 19 month), with good 
quality of life is described. However, anorexia and progressive weight loss are associated with 
worse prognosis (Tham & Vail 2007). Marcy was seen to improve after surgery. She had less 
pruritus and some nodules started to disappear. However, in the first month after surgery new 
nodules began to reappear and she was never pruritus-free. 
Systemic treatments are needed for patients like Marcy, when surgery is not possible or has not 
been successful (eg, cats with cutaneous or intestinal MCTs that are not resectable or are 
metastatic or recurrent after splenectomy). The use of adjuvant systemic treatment might be 
helpful to improve tumor control and survival time following surgery. Rassnick et al. showed in a 
study of 38 cases that lomustine had antitumor activity and was well tolerated in cats with 
cutaneous MCTs when administered at a dosage of 50 to 60 mg/m2. The response rate was of 
50% with a median duration of the response of 168 days. No response was seen in animals 
with splenic involvement. This paper supports the use of lomustine for treatment of cats with 
cutaneous MCTs when surgical treatment is not possible or has not been successful (Rassnick 
et al. 2006).  
Lomustine is an alkylating agent. These agents bind DNA stands, insert an alkyl group, and 
cause DNA breaks. Lomustine is usually used in lymphoma, and histiocytic sarcoma treatment. 
It is moderately expensive and toxic when compared with other drugs (Tham & Vail 2007), but 
its toxic effects in cats have not been well-defined. One study showed neutropenia as a dose-
limiting toxic effect. This was suggested to be a cumulative myelotoxicity that may occurs in cats 
receiving lomustine long term. Hepatic damage due to lomustine usage is reported in dogs. 
Although it was not identified in the cats in the Rassnick et al. study, there was no adequate 
follow-up time to draw meaningful conclusions. Two of the cats receiving lomustine developed 
pleural effusion. Because of those findings, cats on lomustine treatment should be carefully 
evaluated for cumulative myelosuppression and organ damage (Rassnick et al. 2006). 
Isotani et al. in 2006 identified for the first time the presence of c-kit mutation in a cat diagnosed 
with systemic mastocytosis. The same cat was underwent treatment with the tyrosine kinase 
inhibitor, imatinib mesylate, at a dose of 10mg/kg/day PO for 5 weeks without any additional 
treatments such as chemotherapy or steroids. The animal had a dramatic improvement, in 3 
weeks the masses were reduced in size and in 5 weeks they were no longer detectable. The 
number of mast cells in peripheral blood had also decreased in 2 weeks but in 5 weeks the 
count was up to 40cells/uL (Isotani et al. 2006). In another study of 10 cats (2009 Isotani et al.) 
it was found that c-kit mutations were present in 70% of animals. Approximately 65% of cats 
had a mutation in the fifth immunoglobulin domain (IgD), which is different from the dog, where 
mutations are more frequently present in the juxtamembrane domain followed by the fifth IgD. 
Isotani et al. concluded that the mutations in the fifth IgD might be critically involved in the 
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pathogenesis of MCTs in cats. Of the 8 animals that had c-kit mutations, 7 responded to 
treatment with imatinib. Six achieved a partial remission (at least 30% decrease in the sum of 
the longest diameters of target lesions) and one achieved complete remission (disappearance 
of all target lesions) (Isotani et al. 2009).  
Although very limited information is available about the effectiveness of tyrosine kinase 
inhibitors for the treatment of MCTs in cats, Marcy was started on masitinib at the 
recommended dose of 50 mg PO sid. Prednisolone was used at a dose of 0.8mg/kg PO sid in 
order to address Marcy´s pruritus. Prednisolone was also used as chemotherapy drug because 
it binds to the cytoplasmic receptors in mast cells and inhibits DNA synthesis (Tham & Vail 
2007). 
More studies are needed to determine c-kit’s role in feline MCT oncogenesis, and investigate c-
kit expression levels, and KIT protein localization as prognostic indicators. More studies are also 
needed to explore c-KIT as target for therapy with tyrosine kinase inhibitors. Efficacy and 
toxicity of these drugs in cats still needs investigation. The existing studies have a small 
numbers of cats and therefore the conclusions are only preliminary. 
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Anesthesiology Case Report 
Signalment and consult motif: Bubba is an 8 years old male castrated Jack Russell Terrier 
that was referred to the anesthesiology service of UTCVM by the cardiology service of the same 
institution in order to be anesthetized for a pacemaker implantation. 
HISTORY: Bubba had been presented to the cardiology service for evaluation of recurrent 
episodes of syncope that started at least 1 month before. They did not have any obvious trigger. 
When it happened Bubba slumped over to his side and within 2 minutes, he was back to 
normal. Previous CBC and ECG made by the referring veterinarian were been normal. Bubba 
had one episode at his referring veterinary clinic and an atrio-ventricular block and ventricular 
escape beats were seen on ECG. He was referred to the UTCVM in order to be submitted to an 
echocardiogram and a Holter monitorization. Bubba lived in a house with private exterior access 
and has no contact with other animals. He did not contact with garbage or toxic waste. He was 
currently dewormed and vaccinated. His diet was based on premium quality dry food. No other 
abnormalities were noticed when questioned about the different systems and there was no 
relevant previous medical history and was not receiving any medication. 
PHYSICAL EXAM: Bubba was alert and showing a normal behavior. His body condition score 
(BCS) was 5/9, and weighted 8,0 Kg. Normal respiratory rate (40 rpm) and effort; normal lung 
sounds. Heart auscultation showed an irregular rhythm (physiologic sinus arrhythmia seen on 
echo ECG timing lead) and no murmurs or gallop sounds. Bubba had bilateral, symmetric, 
strong and synchronic pulses with a frequency of 110 p.p.m. Pink and moist mucous 
membranes CRT < 2 sec were observed. His rectal temperature was 39ºC, and no parasites or 
blood were seen on the thermometer, a normal anal tonus was also observed. His dehydration 
degree was <5%. All lymph nodes were within the normal limits. No abnormalities were found in 
his abdominal palpation.  
PROBLEM LIST:  Syncopes, atrio-ventricular blocks and escape beats.  
DIFERENTIAL DIAGNOSIS: Myocardical failure; Arrhythmias (bradyarrhythmias: high grade 
second degree heart block; sick sinus syndrome; third degree heart block or tachyarrhythmias: 
Supraventricular tachycardia, ventricular tachycardia); Obstructions to cardiac inflow or outflow 
(valve stenosis, pulmonary hypertension, cardiac tamponade, cardiac masses); Hypoxaemic 
disease; Neurological dysfunction, metabolic disorders and myopathies. 
DIAGNOSIS: Echocardiogram: Normal heart chamber sizes and wall measurements; normal 
left atrial pressure estimate; normal systolic and diastolic function; mild thickening of mitral 
valve. All other valves were normal, no regurgitations and normal outflow tract velocities. 
physiologic sinus arrhythmia seen on echo ECG timing lead. Holter: recorded for 25h 30m and 
with very good quality. The average heart rate was 65 bpm, with a maximum rate of 255 bpm at 
2:58pm (while traveling). The minimum rate was of 30 bpm at 1:58am (while asleep). There 
were 6,621 pauses > 2s, with the longest being 6.86s at 9:25am. Throughout the recording 
period, there were 761 single ventricular complexes, but these were all escape beats (no 
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ventricular premature complexes seen). No supraventricular ectopic beats were seen. CBC, 
chemistry panel and electrolytes: All values were within the normal ranges. 
DIAGNOSIS: Sick Sinus Syndrome (SSS). 
Treatment: Pacemaker implantation 
Anesthesia procedure: Bubba was given butorphanol (0,4 mg/kg IM) to provide sedation to 
catheter placement 4 hours before premedication because the patient arrived early.  
The patient was premedicated with fentanyl (5 mcg/kg IV), and glycopyrrolate (0,01 mg/kg IM) 
30 min before induction was started. Transthoracic pacemaker leads were placed in case 
severe bradycardia occurs during induction. Midazolam (0,5mg/kg, IV) and ketamine (5mg/kg, 
IV) combined in the same syringe were administered for anesthetic induction. Propofol (4mg/kg, 
IV) was administered as a co-induction to effect, until intubation with a 7,0 mm cuffed 
endotracheal tube was possible. Bubba became apneic and was connected to a ventilator using 
a circle anesthetic circuit. Respiratory rate of 9 breaths/min using a tidal volume of 15ml/kg was 
necessary to maintain the patient normocapnic (35-45mmHg). An initial end-tidal 2.5% 
sevoflurane concentration was maintained using 2.0 L/m oxygen flow. Anesthesia was 
maintained with sevoflurane at a median percentage of 2.0% in 1.3L/m of Oxygen and a 
constant-rate infusion of fentanyl (10mcg/kg/hr IV). Fluid therapy was performed with a 
continuous crystalloid infusion of 5ml/kg/hr Plasma-lyte®. 
Oxygen saturation was measured by pulse oximetry (SpO2). End-tidal pressure of carbon 
dioxide (ETCO2) and temperature were monitored with a multiparameter anesthesia monitor. 
Arterial catheter placement was unsuccessful and blood pressure was measured with a non-
invasive blood pressure (NIBP) monitor. A lead II ECG was monitored continuously for changes 
in heart rate and rhythm.  Immediately after anesthesia was induced, SpO2 was 98%, ETCO2 
was 49mmHg and rectal temperature was 37ºC. Pulse rate was 70ppm. No abnormalities were 
observed on ECG during the procedure. Systolic blood pressure was initially 99 mmHg, mean 
was 75mmHg and diastolic was 60mmHg. Those values maintained relatively constant during 
surgery and no anesthetic complications were identified. Cefazolin (22mg/kg) was given IV 
every 90min. For pain management carprofen (4mg/kg SC) was administered before the end of 
anesthesia. Bubba recovered calmly from anesthesia. 
Assessment: Disorders of the sinus node are known as sinus node dysfunction or SSS that 
result from an inadequate impulse formation or conduction. This disease primarily affects the 
sinus node, but abnormalities of the AV conduction system may coexist causing prolonged 
periods of assystole and failure of appropriate escape rhythm generation. (Vailati et al. 2011) 
When the sinus node fails to propagate, the junctional tissues of the heart should depolarize. 
Abnormalities related to SSS pauses of various durations (can last up to 10 seconds) without P 
waves or an escape rhythm. Older female Miniature Schnauzers and west Highland Terriers are 
commonly affected. Syncope is a common complaint. Some dogs do not manifest clinical signs 
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but bradycardias are noticed in routine examination. The prevalence of subclinical SSS is 
unknown. Sinus pauses can be occasionally captured in lead II ECG but in many cases a Holter 
monitoring is necessary to have a diagnosis (Tilley et al. 2007). Permanent pacemaker 
implantation is the ideal treatment for SSS. Pharmacologic therapy is usually of limited value. 
Parasympatholytic (atropine and glycopyrrolate) or sympathomimetic drugs (isoproterenol and 
dobutamine) are used in hope of increasing the ventricular response and reducing the clinical 
signs related with severe bradycardias but long-term control is disappointing (Tilley et al. 2007). 
Bubba`s collapse episodes had characteristic consistent with cardiac syncope (brevity, no pre 
or post-ictal period). Cardiac syncopes can be due to arrhythmias, obstructions to cardiac inflow 
or outflow. The fact that no abnormalities were identified in the echocardiography ruled out 
many of these possibilities. A Holter was performed and the presented pauses were long 
enough to be considered cause of syncope. SSS was diagnosed based on long enough pauses 
(> 2s, longest: 6.86s) and the fact that all 761 single ventricular complexes were escape beats. 
Because these pauses pose a mild to moderate risk for syncope or sudden death if untreated, a 
pacemaker implantation was done. To do so, the anesthesiology service was requested to 
perform anesthesia. 
The anesthetic management of a patient with cardiovascular dysfunction can be very 
challenging, since most preanesthetic and anesthetic agents are capable of CNS depression 
and also capable of producing cardiovascular depression. Patients with cardiovascular 
dysfunction may be more prone to fluid overload and dysrhythmias. Extremes in heart rate may 
cause severe problems, including heart failure. Patients with cardiovascular dysfunction may 
lack sufficient cardiac reserve to compensate for anesthetic induced depression. There can be 
no single suggestion as an anesthetic management techniques or protocol for all animals with 
underlying cardiovascular dysfunction (Seymour & Novakovski 2007). Each individual must be 
assessed with regard to cardiovascular pathophysiology, coexisting systemic or metabolic 
diseases, hemodynamic effects of surgical procedure, influence of anesthesia on the 
cardiovascular system, and potential interactions between the anesthetic and concurrent 
medications (Tilley et al. 2007). 
The decision whether a patient with heart disease should or not be anesthetized begins by 
classifying the patient according to its functional heart failure. The International Small Animal 
Cardiac Health Council provided guidelines for 3 functional classifications of heart disease that 
are based on clinical signs. This classification does not differentiate the type of heart disease 
but provides decision-making guidelines based on the clinical presentation. This classification is 
combined with the classification of physical status for anesthetized patients adopted by the 
American Society of Anesthesiologists (ASA) to assess the anesthetic risk and aid in choosing 
the safest protocol. There are 3 functional grades. The first is the asymptomatic patient with a 
confirmed heart disease but is not presenting clinical signs of heart failure. Those patients can 
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be safely anesthetized without further stabilization. The second classification describes patients 
with mild to moderate clinical signs of heart failure that are evident at rest or with mild exercise. 
Stabilization of clinical signs and the absence of those for several days with drug therapy are 
recommended prior to sedation or anesthesia. When patients of this group need a life-saving 
emergency surgery, they should have parenteral cardiac drug therapy instituted immediately by 
and clinical signs controlled as much as possible before and during anesthesia. The third grade 
corresponds to immediately obvious advanced clinical signs of heart failure. Patients severely 
affected can present in cardiogenic shock and death or severe debilitation is likely without 
therapy. Anesthesia is contraindicated in this third category of patients until clinical signs are 
stabilized with aggressive drug therapy. Owners should be advised of the increased risk of 
death or severe debilitation during or immediately after anesthesia (Tilley et al. 2007). According 
to this classification, Bubba was considered to be in the second group because he had a 
dignosed heart disease and he presented clinical signs (syncopes) The anesthetic risk 
classification can be determined based on physical status (Annex IV-1). Five categories have 
been developed. Unstable patients with clinical signs of cardiac decompensation and heart 
failure are classified as ASA IV and should not be anesthetized until the disease is stabilized. 
Patients in the ASA V category are the ones with a long history of heart disease that is 
refractory to all cardiac drugs. If stabilization of heart failure is not possible, death during 
anesthesia is likely (Tilley et al. 2007). Bubba was considered an ASA IV patient because his 
heart disease could cause him cardiac arrest in any time and bradycardias needed to be 
avoided. However he did not have any systemic signs. 
Premedication has a major impact on the characteristics of the ensuing general anesthesia. 
Making the appropriate selection of drugs concerning each individual can significantly improve 
intraoperative cardiovascular stability, perioperative analgesia and quality of recovery (Seymour 
& Novakovski 2007). In Bubba´s cas, the major concern was to avoid bradycardia. At very low 
heart rates, reduced cardiac output and coronary arterial flow may lead to cardiac arrest. In 
order to avoid it, it is important to choose a pre-anaesthetic medication that does not reduce 
heart rate nor increases systemic vascular resistance (Seymour & Novakovski 2007).  
Because opioids are very attractive drugs to be used in patients with heart disease (they do not 
affect myocardial contractility or vascular tone) fentanyl, a pure Mu agonist opioid, was used 
(Tilley et al. 2007). When administered IV, fentanyl has a fast onset (1-2min) and shot duration 
of action (20-30min). In pain-free dogs like Bubba, doses in the range used to control pain 
generally result in recumbency and sedation. (Seymour & Duke-Novakoski 2007) 
Glycopirrolate, a quaternary ammonium anticholinergic agent, was used as a premedication 
drug in order to prevent the unwanted effects of parasympathetic nervous system caused by 
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For the Induction, a combination of midazolam (0.5mg/kg, IV), ketamine (5mg/kg, IV) and 
Propofol (4mg/kg, IV) was used. Midazolam, was elected to be used due to benzodiazepines 
minor effects in the cardiovascular and respiratory systems. Benzodiazepines produce minimal 
sedation in healthy dogs and therefore are combined with other sedatives. The combination of 
benzodiazepines with ketamine is a stable cardiovascular combination. The administration of a 
low dose of ketamine is a strategy to manage low heart rates because it has sympathomimetic 
properties. Ketamine is a dissociative agent with a very fast onset of action (30-90 sec). It 
produces a dose-dependent CNS depression that leads to a dissociative state, characterized by 
profound analgesia and amnesia with maintained ocular, laryngeal and pharyngeal reflexes. 
Ketamine anesthesia is associated with increased muscle tone, muscle spasm and seizures. 
The combination with midazolam helps to reduce these side effects and to obtain a surgical 
state of anesthesia. The main reason for the choice of ketamine was its unique cardiovascular 
effects due to the central stimulation of the sympathetic system. Unlike other intravenous 
anesthetics, it stimulates the cardiovascular system, resulting in increases in heart rate, blood 
pressure and cardiac output. However, this raise in hemodynamic variables is associated with 
an increased myocardical work and oxygen consumption. A healthy heart can enhance its 
oxygen supply by coronary vasodilatation and increased cardiac output but in compromised 
hearts (hypertrophic) may not be able to mount such response (Seymour & Duke-Novakoski 
2007). 
Propofol is a hypnotic agent with a rapid onset (60-90sec) and short duration of action (10 min). 
Its hypnotic action is mainly mediated by interaction with the GABAA receptor subunit, 
potentiating the GABA-induced chloride current. The most prominent hemodynamic effect of 
propofol is moderate hypotension due to reduction in cardiac output and systemic vascular 
resistance. In patients with pre-existing bradycardias, like Bubba with his SSS, refractory 
bradicardia or asystole can occur. For this reason transthoracic pacemaker leads were placed 
before propofol administration and a low dose was used (4mg/kg; dose range. 2-6mg/kg). The 
administration of glycopyrrolate and ketamine was also a preventive procedure to avoid 
refractory bradycardias and hypotension. Respiratory depression can be caused by the rapid 
injection of propofol. (Seymour & Duke-Novakoski 2007) This was observed in Bubba and he 
was connected to a ventilator troughout the entire procedure.  
A balanced anesthesia was performed using a volatile agent (Sevoflurane) and a continuous 
rate infusion of fentanyl. The analgesic and anaesthetic-sparing properties of this combination 
allows for the reduction of the concentration of volatile agents hence less cardiovascular 
depression. (Seymour & Duke-Novakoski 2007) Sevoflurane, a fluorinated ether less potent 
than isoflurane, was chosen for Bubba´s anesthesia. Due to the sevoflorane lower solubility, 
when compared with isoflurane, faster changes in the depth of anesthesia are possible. The 
cardiovascular depression is similar to that observed with isoflurane, but the degree of 
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respiratory depression is less profound with sevoflurane. (Seymour & Duke-Novakoski 2007). 
Bennett et al. (2008) compared the anesthetic characteristic of sevoflurane and isoflurane under 
routine veterinary clinical conditions by studying, 108 dogs. The dogs did not receive the same 
premedication nor induction protocol. The cardiovascular and respiratory functions were 
generally similar in the two groups. However there was a range of different premedication 
protocols, a wide range of dog sizes and breeds and different procedures were undertaken, 
facts that may have obscured small differences between the two groups. Both isoflorane and 
sevoflurane decreased arterial systolic blood pressure by the reduction of systemic vascular 
resistance. The respiratory effects were also fairly the same but in this specific study 
sevoflurane caused more respiratory depression than isoflurane. (Bennett et al. 2008) 
Fentanyl and midazolam are frequently administered as constant rate infusions to reduce 
inhalant anesthetic requirements and subsequent unwanted hypotension (Saunder et al.2009). 
Saunder et al. (2009) measured the cardiac troponin I and C-reactive protein concentrations in 
20 dogs, in order to study the myocardial injury caused by ischemia during anesthesia using 
sevoflurane or its combination with fentanyl and midazolam. In Saunders study fentanyl and 
midazolam when used in combination with sevoflurane had anesthetic sparing effect by 
requiring less volatile anesthetic to maintain an appropriate plane of anesthesia. However, when 
it comes to the comparative protective myocardical effects of those two protocols, conclusions 
are still to be determined and further studies are needed (Saunders et al. 2009). Bubba´s 
anesthesia was maintained with a low end-tidal sevoflurane (2.0%) which is an under the 2.4%, 
sevoflurane MAC. This protocol showed to be a successful approach in this case because 
neither bradycardias nor hypotension were observed.  
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Appendix I: Ophthalmology Appendix 
1. 1. Spice ERG:  
 
 
2. Spice´s US OD and OS: Bilateral primary intumescent cataracts. Shallow anterior 
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Appendix II: Neurology Appendix: 
















2.Osteochondrosis of the cranial endplate of S1, normal intervertebral spaces. Left lombo-


















3.T2 transverse sequence: comparison between L6-L7 (image A) and L7-S1 (image B). Loss of 
epidural fat and spinal roots compression is visible in L7-S1. The left side spinal roots are more 
compressed than the right side spinal roots. 
 
 
T1 transverse sequence: comparison between L6-L7 (image A) and L7-S1 (image B). Loss of 
epidural fat and spinal roots compression is visible in L7-S1. The left side spinal roots are visible 
more compressed than the right side spinal roots. 
 




T2 Sagittal Sequence: compression of L7-S1 by hypointense tissue (Hansen II disc herniation). 

































Proton weight density transverse sequence: Ovoid fragment at the craniodorsal aspect of S1, 
lying in the left ventral aspect of the vertebral canal. Circled in image B and not circled in A.  




Appendix III: Anesthesiology Appendix: 

















2. Bubba´s Anesthesia Form: 
